Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Utilization of Decision Aids for Tamoxifen Treatment in Breast Cancer Patients
NCT02488603Unknown
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Aug 2015
- Primary completion
- Aug 2018
01
Overview
Randomised, open-label trial (2 arms), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoint: Change in Knowledge of Tamoxifen Scale at 4 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT02488603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02488603.